Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
5.0%
1w
6.9%
1m
2.8%
3m
35.7%
6m
53.4%
1y
107.7%
all
63.7%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

795 5.0%
535
969
Company Overview

Sales
873 Cr
Growth: -0.3%
Profit after Tax
235 Cr
Growth: 39.8%
Mid Cap
13,790 Cr
P/E: 58.7x
Industry P/E: 32.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 873
Growth -0.3%
EBITDA 33.3%
P/S 15.8x
Dividend 0.2%
P/E 58.7x
Book Value ₹ 60
PEG Ratio -193.1x
ROE 25.3%
P/B 13.3x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)